Hoppa till innehåll
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Språk
Alla fält
Titel
Upphovsman
Ämne
Signum
ISBN/ISSN
Tagg
Sök
Avancerad
IN PATIENTS WITH ANKYLOSING SP...
Hänvisa
Textmeddelande
Skicka per e-post
Skriv ut
Exportera posten
Exportera till: RefWorks
Exportera till: EndNoteWeb
Exportera till: EndNote
Permanent länk
IN PATIENTS WITH ANKYLOSING SPONDYLITIS (AS), ADALIMUMAB IMPROVES INFLAMMATORY BOWEL DISEASE (IBD) AND PSORIASIS (Ps) AND PREVENTS ANTERIOR UVEITIS (AU) FLARES
Bibliografiska uppgifter
Huvudupphovsmän:
Wordsworth, P
,
Rudwaleit, M
,
Claudepierre, P
,
Loza, E
,
Olivieri, I
,
Wong, R
,
Oezer, U
,
Kary, S
,
Kupper, H
Materialtyp:
Conference item
Publicerad:
2009
Beståndsuppgifter
Beskrivning
Liknande verk
Katalogiseringsuppgifter
Liknande verk
Adalimumab (HUMIRA (R)) improves inflammatory bowel disease (IBD) and psoriasis (Ps) and prevents anterior uveitis (AU) flares in patients with Ankylosing spondylitis (AS)
av: Rudwaleit, M, et al.
Publicerad: (2008)
Predictors of good clinical response (BASDAI 50 or ASAS partial remission) in 1,250 patients treated with adalimumab (humira (R)) for active ankylosing spondylitis (AS)
av: Rudwaleit, M, et al.
Publicerad: (2008)
Effectiveness, safety, and predictors of good clinical response in 1250 patients treated with adalimumab for active ankylosing spondylitis.
av: Rudwaleit, M, et al.
Publicerad: (2009)
Adalimumab is effective and well-tolerated in patients with ankylosing spondylitis (AS) in day-to-day clinical practice - Results from rhapsody
av: Wordsworth, P, et al.
Publicerad: (2008)
Efficacy of adalimumab in uveitis in patients with ankylosing spondylitis
av: Shandor Fedorovich Erdes
Publicerad: (2012-03-01)